Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51,654,406
-
Total 13F shares
-
1,283,324
-
Share change
-
+270,482
-
Total reported value
-
$6,365,000
-
Price per share
-
$4.96
-
Number of holders
-
14
-
Value change
-
+$1,445,583
-
Number of buys
-
10
-
Number of sells
-
4
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q2 2019
As of 30 Jun 2019,
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,283,324 shares.
The largest 10 holders included
Wexford Capital LP, Manatuck Hill Partners, LLC, Granite Point Capital Management, L.P., Worth Venture Partners, LLC, MILLENNIUM MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, Eidelman Virant Capital, VANGUARD GROUP INC, BlackRock Inc., and UBS Group AG.
This page lists
14
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.